proteomics technology for analysis (Bioprofile Testing)
86
Structured Review
Bioprofile Testing
proteomics technology for analysis
Proteomics Technology For Analysis, supplied by Bioprofile Testing, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteomics+technology+for+analysis/analysis+for+proteomics+technology/pm42105623-443-16-20
Average 86 stars, based on 1 article reviews
Proteomics Technology For Analysis, supplied by Bioprofile Testing, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteomics+technology+for+analysis/analysis+for+proteomics+technology/pm42105623-443-16-20
Average 86 stars, based on 1 article reviews
proteomics technology for analysis - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Knockdown:Article Title: Targeting the USP5-HSPB1 axis overcomes ferroptosis resistance in intrahepatic cholangiocarcinoma. Article Snippet: Ferroptosis evasion contributes to therapeutic resistance in intrahepatic cholangiocarcinoma (ICC), yet the ubiquitin-dependent mechanisms governing this process remain poorly defined.. Here, we identify ubiquitinspecific protease 5 (USP5) as a clinically relevant ferroptosis suppressor in ICC.. USP5 was frequently upregulated in human ICC specimens, and elevated USP5 expression was associated with adverse clinicopathological features and poor outcomes. Expressing:Article Title: Targeting the USP5-HSPB1 axis overcomes ferroptosis resistance in intrahepatic cholangiocarcinoma. Article Snippet: Ferroptosis evasion contributes to therapeutic resistance in intrahepatic cholangiocarcinoma (ICC), yet the ubiquitin-dependent mechanisms governing this process remain poorly defined.. Here, we identify ubiquitinspecific protease 5 (USP5) as a clinically relevant ferroptosis suppressor in ICC.. USP5 was frequently upregulated in human ICC specimens, and elevated USP5 expression was associated with adverse clinicopathological features and poor outcomes. Multiplex sample analysis:Article Title: Targeting the USP5-HSPB1 axis overcomes ferroptosis resistance in intrahepatic cholangiocarcinoma. Article Snippet: Ferroptosis evasion contributes to therapeutic resistance in intrahepatic cholangiocarcinoma (ICC), yet the ubiquitin-dependent mechanisms governing this process remain poorly defined.. Here, we identify ubiquitinspecific protease 5 (USP5) as a clinically relevant ferroptosis suppressor in ICC.. USP5 was frequently upregulated in human ICC specimens, and elevated USP5 expression was associated with adverse clinicopathological features and poor outcomes. Quantitative Proteomics:Article Title: Targeting the USP5-HSPB1 axis overcomes ferroptosis resistance in intrahepatic cholangiocarcinoma. Article Snippet: Ferroptosis evasion contributes to therapeutic resistance in intrahepatic cholangiocarcinoma (ICC), yet the ubiquitin-dependent mechanisms governing this process remain poorly defined.. Here, we identify ubiquitinspecific protease 5 (USP5) as a clinically relevant ferroptosis suppressor in ICC.. USP5 was frequently upregulated in human ICC specimens, and elevated USP5 expression was associated with adverse clinicopathological features and poor outcomes. |